RDD

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award

Retrieved on: 
星期三, 五月 8, 2024
Biotechnology, Manufacturing, Other Health, Health, General Health, Pharmaceutical, Other Science, Medical Devices, Research, Other Manufacturing, Science, School, SAB, Insulin, Publication, Infection, Pharmacy school, Conference, Virginia Commonwealth University, Multimedia, RDD, Inhalation, Pharmaceutical industry

At the recent Respiratory Drug Delivery (RDD) Conference, John Patton , Ph.D., biotechnology scientist and entrepreneur and Head of the Scientific Advisory Board (SAB) for Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, was announced as the winner of the Charles G. Thiel Award .

Key Points: 
  • At the recent Respiratory Drug Delivery (RDD) Conference, John Patton , Ph.D., biotechnology scientist and entrepreneur and Head of the Scientific Advisory Board (SAB) for Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, was announced as the winner of the Charles G. Thiel Award .
  • View the full release here: https://www.businesswire.com/news/home/20240508931671/en/
    Biotechnology scientist and entrepreneur and Kindeva Drug Delivery’s Head of the Scientific Advisory Board, John Patton (second from the left), was named the winner of the Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery at this year’s Respiratory Drug Delivery (RDD) Conference.
  • Also pictured (from left to right): Michael Hindle, Ph.D., Professor, School of Pharmacy at Virginia Commonwealth University, Stephen Stein, Scientific Director of Inhalation Product Development at Kindeva, and Milton Boyer, CEO at Kindeva.
  • John has made and continues to make a tremendous contribution to both Kindeva and the wider industry.

Nebu-Flow secures additional investment to accelerate next generation respiratory pharmaceuticals

Retrieved on: 
星期一, 四月 29, 2024
Medical Devices, Health, Pharmaceutical, Health Technology, Cardiology, Disability, United, Innovation, Death, RNA, Conference, Scottish Enterprise, Conduit, Patient, Innovate UK, Multimedia, RDD, Pharmaceutical industry

Nebu-Flow has secured an additional $5.9 million of investment to accelerate the next generation of inhaled drugs for patients with respiratory disorders, which are the main cause of death and disability worldwide.

Key Points: 
  • Nebu-Flow has secured an additional $5.9 million of investment to accelerate the next generation of inhaled drugs for patients with respiratory disorders, which are the main cause of death and disability worldwide.
  • Dr Elijah Nazarzadeh, CEO and co-founder of Nebu-Flow, said: “Our mission is to revolutionize respiratory drug delivery.
  • This investment underscores our confidence in Nebu-Flow’s groundbreaking nebulisation technology, which is poised to transform respiratory drug delivery, improve health and deliver impact."
  • - Nebu-Flow is featuring at this year’s Respiratory Drug Delivery Conference, RDD 2024 , in Tucson, Arizona between 5th-9th May.

AIChE Selected by DOE to Lead New Hydrogen Electrolyzer and Fuel Cell Recycling Consortium 

Retrieved on: 
星期二, 三月 26, 2024
Hydrogen, Delaware State University, University of Houston, Worcester Polytechnic Institute, Plug Power, Oak Ridge National Laboratory, National Renewable Energy Laboratory, Recycling, Chemours, Research, University, American Institute, RDD, University of Delaware, RD, DOE, General Motors, Electrolysis, Renewable energy

Among the recipients, the American Institute of Chemical Engineers (AIChE) was selected to lead H2CIRC, a new “recovery and recycling” consortium charged with developing innovative and practical approaches to enable the recovery, recycling, and reuse of materials and components for hydrogen fuel cells and electrolyzers.

Key Points: 
  • Among the recipients, the American Institute of Chemical Engineers (AIChE) was selected to lead H2CIRC, a new “recovery and recycling” consortium charged with developing innovative and practical approaches to enable the recovery, recycling, and reuse of materials and components for hydrogen fuel cells and electrolyzers.
  • This development will be supported by federal funding to be awarded to AIChE for the Hydrogen Electrolyzer and Fuel Cell Recycling Consortium, which totals $50 million over five years.
  • Additional DOE funding is being awarded for projects including low-cost, high-throughput electrolyzer manufacturing; electrolyzer component and supply chain development; advanced technology and component development; advanced manufacturing of fuel cell assemblies and stacks; and fuel cell supply chain development.
  • AIChE and its consortium partners will establish a blueprint across the industry for recycling electrolyzer and fuel cell systems and components, aimed at securing long-term supply chain security and environmental sustainability.

ACT and NREL Forge Alliance to Drive Sustainable Aviation Innovation

Retrieved on: 
星期一, 三月 11, 2024
ACT, BCG, Boston Consulting Group, MOU, Organization, National Renewable Energy Laboratory, GHG, SAN, SAFARI, Aviation, Carbon, RDD, CO2, Hydrogen, NREL, SAF

ACT, with a charitable mission to shape the future of sustainable flight, has unveiled its latest endeavor, the Systemic Approaches for Aviation Research Initiative (SAFARI).

Key Points: 
  • ACT, with a charitable mission to shape the future of sustainable flight, has unveiled its latest endeavor, the Systemic Approaches for Aviation Research Initiative (SAFARI).
  • Doug Arent, NREL executive director of strategic public-private partnerships, stated, "Decarbonizing aviation demands unprecedented collaboration to de-risk dynamic supply chains and rapidly deploy new energy technologies.
  • The laboratory's sustainable aviation initiative aims to develop decarbonization pathways with a holistic perspective to address all energy aspects of the aviation ecosystem—from net-zero-carbon energy sources to infrastructure optimization and aircraft propulsion technologies.
  • Tom Light, CEO of ACT, said, "Addressing these challenges requires a combination of public and private funding, including philanthropic contributions.

JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community

Retrieved on: 
星期四, 二月 29, 2024
Health, Other Science, General Health, Research, Science, Pharmaceutical, Biotechnology, JCR, Anxiety, Caregiver, Physician, Dream, Quality of life, Hope, RDD, DSM-IV codes, Rare Disease Day, Disease, Internal, Pharmaceutical industry

RDD activities aim to raise awareness of rare diseases and to improve the quality of life of individuals with rare and intractable diseases through better diagnoses and treatments.

Key Points: 
  • RDD activities aim to raise awareness of rare diseases and to improve the quality of life of individuals with rare and intractable diseases through better diagnoses and treatments.
  • JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) endorses the important mission of RDD and will advocate for RDD 2024 in Japan.
  • There are more than 6,000 rare diseases with an estimated 300 million individuals worldwide living with a rare disease.
  • Highlights of external awareness raising-activities for RDD:
    For JCR, RDD does not stop on the last day of February; it reminds us of our purpose every day to help raise awareness and generate change for the rare disease community worldwide.

Ault Alliance Announces that Its Indirect Subsidiary, MTIX, Ltd. Provides Substantial Cost Savings and Environmental Benefits From Using Its Proprietary MLSE Process

Retrieved on: 
星期四, 十一月 30, 2023
Environment, Technology, Textiles, Chemicals, Plastics, Other Technology, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Hardware, ISPO, RDD, NYSE, Plasma, Multimedia, Textile, 2023, MLSE, Life-cycle assessment, SHI International Corp, Water, Electricity, Textile industry, LCA

Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), announced today that MTIX Ltd. (“MTIX”), a wholly owned subsidiary of the Company’s majority owned subsidiary, Avalanche International Corp., has achieved substantial cost savings and environmental benefits with a digital scouring process algorithm associated with its license with PANGAIA.

Key Points: 
  • Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), announced today that MTIX Ltd. (“MTIX”), a wholly owned subsidiary of the Company’s majority owned subsidiary, Avalanche International Corp., has achieved substantial cost savings and environmental benefits with a digital scouring process algorithm associated with its license with PANGAIA.
  • This innovative approach aims to save water and energy as well as process chemicals efficiently.
  • RDD Textiles is showcasing this fabric along with its other innovations at ISPO 2023 in Munich, Germany this week Booth #C1.327.
  • Phil Mansour, the CEO of MTIX, stated, “We are pleased at the results of the combined efforts of our teams.

NFRA Convention 2023: A Landmark Event for the Frozen & Refrigerated Foods Industry

Retrieved on: 
星期二, 十月 31, 2023
Cream, Frozen, Convention center, Food industry, Gaylord National Resort & Convention Center, National Frozen & Refrigerated Foods Association, Brookshire's Food & Pharmacy, RDD, UNFI, Acosta Sales & Marketing, Land O'Lakes, Marketing, National Harbor, Maryland, Retirement, Price, Convention, Taste, Ice cream, NFRA, Nightclub, Film industry, Tourism, Fame, MD

HARRISBURG, Pa., Oct. 31, 2023 /PRNewswire/ -- The 2023 NFRA Convention, hosted by the National Frozen & Refrigerated Foods Association (NFRA), marked a record-breaking year with nearly 1,600 attendees from all sectors of the frozen and refrigerated foods industry. The event featured powerful networking opportunities, exciting product innovations, and celebrated various industry achievements.

Key Points: 
  • HARRISBURG, Pa., Oct. 31, 2023 /PRNewswire/ -- The 2023 NFRA Convention, hosted by the National Frozen & Refrigerated Foods Association (NFRA), marked a record-breaking year with nearly 1,600 attendees from all sectors of the frozen and refrigerated foods industry.
  • Refrigerated Hall of Fame Inductees: The Refrigerated Food Hall of Fame, established in 2010, recognizes outstanding individuals in the refrigerated food industry.
  • Top Marketers Honored: The prestigious 2023 Golden Penguin Awards for exceptional achievements in marketing and merchandising within the frozen and refrigerated foods industry were presented.
  • The 2024 NFRA Convention will be held at the Gaylord National Resort & Convention Center, National Harbor, MD, October 5-8, 2024.

OS Therapies Announces Full Enrollment in PhIIb Clinical Trial AOST-2121 in Recurred, Resected Osteosarcoma with OST-HER2 (Listeria monocytogenes) for Delay or Prevention of Recurrence

Retrieved on: 
星期二, 九月 26, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Fast, Clinical trial, OS, Cancer, AYA, RDD, COG, BTD, Prognosis, Rated R, HIV disease progression rates, USDA, Patient, Physician, Principle, OST, Recurrence, Metastasis, Disease, Pharmaceutical industry, Osteosarcoma, MD

OS Therapies, a research and clinical stage biopharmaceutical company, is extremely excited to announce Full Enrollment for its lead OST-HER2 (OST31-164) program in its ongoing clinical trial AOST-2121 (NCT04974008).

Key Points: 
  • OS Therapies, a research and clinical stage biopharmaceutical company, is extremely excited to announce Full Enrollment for its lead OST-HER2 (OST31-164) program in its ongoing clinical trial AOST-2121 (NCT04974008).
  • “Several patients have completed the treatment phase of the trial and many more are undergoing treatment with OST-HER2.
  • OS Therapies has two platform technologies: OST-HER2 and OST-TDC being developed for therapies to treat Osteosarcoma (OS) and other solid tumors including ovarian.
  • AOST-2121 is a Phase IIB clinical trial intended to prevent or delay metastasis and improve Overall Survival (OS) in Osteosarcoma.

Avelo Airlines Flies its First One Million Customers at its Los Angeles / Burbank Base

Retrieved on: 
星期五, 九月 1, 2023
MFR, Travel, Kalispell, Montana, Boeing, Atmosphere, Culture, Airport, RDD, STS, EUG, History, BZN, Fodor's, BUR, COS, Hollywood Burbank Airport, Air travel, ACV, Customer, RDM, FCA, City, BRO, LOS, BOI, PSC, TSA, Tourism, Airline, L.A, Avelo Airlines

This week, Avelo also surpassed carrying three million Customers systemwide since the airline's debut.

Key Points: 
  • This week, Avelo also surpassed carrying three million Customers systemwide since the airline's debut.
  • Avelo Airlines CEO and Founder Andrew Levy said, "From the start, Avelo has been on a mission to Inspire Travel by making flying affordable and easy so that our Customers can travel more.
  • I appreciate our L.A. Customers for choosing Avelo and our BUR-based Crewmembers for making Avelo the easy way to 13 popular nonstop destinations."
  • In addition to offering Customers everyday low fares on every route, Avelo Customers can always change or cancel their itineraries with no extra fees.

AST Awarded $49M PICSSS Contract from the U.S. Department of Energy

Retrieved on: 
星期二, 六月 6, 2023
Science, Computer Support Services, RDD, AST, Multimedia, NE, Office of Nuclear Energy, Office of Inspector General, U.S. Department of Health and Human Services, DOE, Consultant, U.S. Department of Energy, Office of Inspector General, Management, Nursing

BRIDGEPORT, W.Va., June 6, 2023 /PRNewswire/ -- Allegheny Science & Technology (AST), a woman-owned energy and technology solutions firm, has been awarded a five-year contract valued at $49M.

Key Points: 
  • BRIDGEPORT, W.Va., June 6, 2023 /PRNewswire/ -- Allegheny Science & Technology (AST), a woman-owned energy and technology solutions firm, has been awarded a five-year contract valued at $49M.
  • The Program Information Collection System and Support Services (PICSSS) contract provides essential support for the U.S. Department of Energy's (DOE) Office of Nuclear Energy's (NE) portfolio worth almost $15B.
  • With the PICSSS contract appointment, AST will support the DOE's mission-critical research, development, demonstration, and deployment (RDD&D) programs while providing real-time project progress and milestone data.
  • Utilizing scientists, consultants, and subject matter experts, AST delivers innovative solutions that drive clean, affordable, and sustainable energy technologies for its clients.